Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.

Neurology - 6 Jan 2009

Mitchell R M, Freeman W M, Randazzo W T, Stephens H E, Beard J L, Simmons Z, Connor J R

Abstract excerpt

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with complicated pathogenesis that poses challenges with respect to diagnosis and monitoring of disease progression. OBJECTIVES: To identify a biomarker panel that elucidates ALS disease pathogenesis, disti...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acids
Share to Amyotrophic Lateral Sclerosis
Share to beta 2-Microglobulin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemochromatosis Protein

Share to Histocompatibility Antigens Class I

Share to Intercellular Signaling Peptides and Proteins

Share to Nervous System Diseases

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 18987350
DOI: 10.1212/01.wnl.0000333251.36681.a5

Genes

HFE

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18987350-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.PMID 18987350Read ↗

Plasma biomarkers associated with ALS and their relationship to iron homeostasis.Semantic proximity Read ↗

Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes.Semantic proximity Read ↗

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applicationsSemantic proximity Read ↗

Network Analysis of the Cerebrospinal Fluid Proteome Reveals Shared and Unique Differences Between Sporadic and Familial Forms of Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Biomarkers for amyotrophic lateral sclerosis.Semantic proximity Read ↗

Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosisSemantic proximity Read ↗

A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosisSemantic proximity Read ↗

Proteomic profiling of CSF reveals stage-specific changes in Amyotrophic lateral sclerosis patientsSemantic proximity Read ↗

ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia.Semantic proximity Read ↗

Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosisSemantic proximity Read ↗

Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosisSemantic proximity Read ↗

High-Plex CSF proteomics reveals a distinct vascular- immune signature in β-amyloid-negative corticobasal syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.